Nanotechnology Now - Press Release: "Nanomedicine Webinar Series Designed for Medical, Industry and Reserach Communities"

Home > Press > Nanomedicine Webinar Series Designed for Medical, Industry and Reserach Communities

Abstract:
CME Accredited Live and On-demand Sessions Now Available

Nanomedicine Webinar Series Designed for Medical, Industry and Reserach Communities

San Diego, CA | Posted on April 21st, 2010

NanoTecNexus (NTN), formerly NanoBioNexus, already acclaimed for its educational forums and nanobiotechnology expertise, announces the second installment of courses, seminars, and lectures to be delivered online with proven and easy to use webinar tools. Delivering online webinars is part of NTN's strategy to reach broad geographically dispersed communities, leverage scientific, medical, and business experts worldwide, and deliver the highest caliber content in a cost-effective manner.

Nanomedicine 2: New Strategies and Innovations to Understand, Treat and Monitor Disease is a continuation of the highly successful Nanomedicine 1 webinar series, a first of its kind Continuing Medical Education (CME) accredited webinar series sponsored by the UC San Diego School of Medicine and produced in partnership with the UC San Diego NanoTumor Center (NTC). The first of six Nanomedicine 2 sessions is scheduled for Tuesday, April 27, 2010, at 8:00AM Pacific. Brochure and details here.

The NanoTumor Center, a public-private consortium funded by the National Cancer Institute Alliance for Nanotechnology and led by UC San Diego, is dedicated to the translational application of nanotechnology in the fight against cancer. NanoTecNexus, a member of this consortium and lead for the NTC educational projects, led the planning committee in the design and organization of the webinar series to meet the accreditation standards and requirements.

"Education in the new field of cancer nanotechnology for the scientific and clinical communities as well as the general public is an integral part of our center," said NTC Director Sadik Esener, PhD, Professor of Electrical and Computer Engineering at the UCSD Jacobs School of Engineering.
The Nanomedicine 2 webinar series also follows a Business and Technology Series designed for the research, industry, and investment communities worldwide as well as the general public interested in learning about progress made in nanotechnology development. The goal is to educate on the translational progress of applications using nanotechnology. "We are committed to fill an important void and place the attention on real progress, not just promise or hype," said Adriana Vela, Founder and CEO of NanoTecNexus. "I am proud to say that, since our inception, we have not wavered from delivering quality content with top expert presenters."

For a full schedule of upcoming Nanomedicine or Business and Technology series webinars, visit www.nanotecnexus.org.

####

About NanoTecNexus
NanoTecNexus (NTN), formerly known as NanoBioNexus, is a leading non-profit organization headquartered in San Diego with offices in Tucson AZ, San Jose, CA and Vancouver, WA. NTN is dedicated to catalyzing collaboration and knowledge exchange in the nanotech field by connecting people, technology, industry and investment. NanoTecNexus enables constituents worldwide to keep up-to-date on the developments of cutting-edge nanotechnologies.

Nanotechnology involves manipulating matter at the atomic or molecular scale smaller than 100 nanometers (1 nm=1 billionths of a meter) and taking advantage of properties that are present at that scale. Nanotechnology is used in thousands of applications in medicine and health, energy and water, defense and many others.

About Moores UCSD Cancer Center
The Moores UCSD Cancer Center is one of the nation’s 41 National Cancer Institute-designated Comprehensive Cancer Centers, combining research, clinical care and community outreach to advance the prevention, treatment and cure of cancer. For more information, visit www.cancer.ucsd.edu.

About the NanoTumor Center
The NTC is a five-year, $20-million National Cancer Institute (NCI)-funded public-private consortium and one of only eight such NCI-backed programs in the nation. UCSD physicians, engineers, chemists and biologists collaborate with colleagues at the Burnham Institute for Medical Research, in addition to various industry partners, to examine the potential uses of nanotechnology in cancer detection, imaging and treatment. For more information, visit ntc-ccne.org

For more information, please click here

Contacts:
Principal Contact
Adriana Vela

(858)-774-8283

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: